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Dear Sirs, 
Neuromyelitis optica (NMO) is a rare autoimmune disease associated with inflammation of the 
optic nerves, spinal cord and brainstem [1]. In addition to physical and visual problems, 
cognitive dysfunction is also common among people with NMO (pwNMO) [2], but is 
potentially under-recognised and incompletely evaluated in routine clinical care. We aimed to 
investigate the spectrum of cognitive impairment in pwNMO presenting to a specialist clinic 
using a brief cognitive battery administered on a touchscreen tablet computer. 
All pwNMO attending the Anne Rowling Regenerative Neurology Clinic, University of 
Edinburgh, between February 2014 and February 2015 were offered the opportunity to 
complete the cognitive tasks as part of their routine holistic clinical assessment. Three tests 
from the Cambridge Neuropsychological Test Automated Battery (CANTAB) (assessing five 
different domains of cognition) were administered using a touchscreen tablet computer (iPad 
Air, Apple Inc.): 
1. Match to Sample (MTS): assesses processing speed and attention 
2. Paired Associates Learning (PAL): assesses visuospatial episodic memory 
3. Spatial Working Memory (SWM): assesses working memory and executive function 
These took approximately 15 minutes to complete. Each task incorporated an automated 
computer voiceover providing instructions to patients and required no prior 
neuropsychological training for administration. Patients were also screened for depression 
using a touchscreen version of the 15-item Geriatric Depression Scale [3], which has high 
diagnostic sensitivity and specificity in the general adult population [4]. Upon completion, raw 
scores for each cognitive domain were processed by the software to create z-scores 
standardised for age, sex and education status using data from an inbuilt normative database 
collected from healthy adults aged 18-90 years. Based on these z-scores, cognitive performance 
levels were categorised from ‘superior’ (z-score > 1.5) to ‘very poor’ (z-score < -2), though 
‘average’ (z-score ≥ -1) was the highest possible category for some tests. Patients scoring 
‘poor’ or ‘very poor’ (z-score < -1.5) in a cognitive domain were considered to be impaired 
relative to their age, sex and education-matched peers. 
Sixteen pwNMO (62.5% female) completed the CANTAB assessments (mean age 48.6 ± 17 
years, range: 18 - 83 years). Cognitive impairment was detected in at least one cognitive 
domain in seven patients (43.8% of the sample). Two patients (12.5% of the sample) exhibited 
impairment in two cognitive domains. Across the sample, impairments were observed on 
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measures of working memory (12.5%), episodic memory (18.8%) and executive function 
(25%). None of the patients exhibited impairments in processing speed or attention. Clinically 
significant depressive symptoms were reported in 43.8% of patients, but were not associated 
with the presence of cognitive impairment. 
These results confirm that cognitive impairment is common and occurs across a range of 
domains among pwNMO. These findings also further corroborate reports that suggest that the 
effects of NMO may extend beyond the optic nerve and spinal cord and into the brain [2, 5, 6]. 
The overall proportion of individuals exhibiting impairment was similar to another recent study 
conducted at the same clinic in patients with multiple sclerosis, though the profile of 
impairment differed slightly between disorders [7]. The absence of impairments in processing 
speed or attention in this NMO sample is interesting as it conflicts with previous findings [2], 
but also suggests that the impairments observed in other aspects of cognition were not 
attributable to visual or motor problems, or to potential sedating effects of pain medications 
[8]. Collectively, these results support recent calls for the use of routine cognitive screening in 
NMO [1], and demonstrate that computerised cognitive assessments could offer a practical 
solution to the lack of time, specialist resources and expertise typically required to administer, 
score and interpret paper-and-pencil based measures in everyday clinical practice. 
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